Literature DB >> 30993427

Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.

Michael Baboudjian1, Khalid Al-Balushi1, Floriane Michel1, Francois Lannes2, Akram Akiki1, Sarah Gaillet1,2, Veronique Delaporte2, Evelyne Ragni2, Harry Toledano2, Gilles Karsenty1, Dominique Rossi2, Cyrille Bastide2, Eric Lechevallier1, Romain Boissier3.   

Abstract

PURPOSE: There have recent reports in the literature of increased rates of bladder recurrence (BR) after radical nephroureterectomy (RNU) when diagnostic flexible ureteroscopy (DFU) was performed before RNU. The technical heterogeneity of DFU was a major bias in these studies. Our purpose was to evaluate the impact of a standardized DFU technique before RNU on the risk of BR.
METHODS: A retrospective monocenter study including patients who underwent RNU for upper tract urothelial carcinoma (UTUC) between 2005 and 2017. 171 patients were identified. 78 patients were excluded owing to a history of bladder cancer before RNU or neo-adjuvant/adjuvant chemotherapy. 93 included patients were stratified according to pre-RNU ureteroscopy (DFU + 70 patients) or no pre-RNU ureteroscopy (DFU-23 patients). The standardized DFU technique consisted of systematic ureteral sheath (ch9-10), flexible ureteroscopy, biopsy, and drainage with a mono-J/bladder catheter to avoid contact of contaminated urine of the upper tract with the bladder.
RESULTS: Epidemiological, initial staging, and postoperative tumoral characteristics were similar in both groups. Mean follow-up was 35 months [2-166], 47(50%) BR occurred with 41(87%) in the DFU + group, and pre-RNU-DFU was an independent predictive factor of BR (OR = 4[1.4-11.9], P = 0.01) (Cox regression model). The characteristics of BR were similar in both groups, although BR occurred earlier in DFU + (427 days vs. 226 days (P = 0.07)).
CONCLUSION: Bladder recurrence after diagnostic ureteroscopy + nephroureterectomy was high despite technical precautions to avoid contact of bladder mucosa with contaminated urine from the upper urinary tract. Post-DFU endovesical instillation should be investigated.

Entities:  

Keywords:  Bladder recurrence; Endoscopy; Nephroureterectomy; Ureteroscopy; Urothelial tumor

Mesh:

Year:  2019        PMID: 30993427     DOI: 10.1007/s00345-019-02768-w

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  23 in total

1.  Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract.

Authors:  Shuhei Ishikawa; Takashige Abe; Nobuo Shinohara; Toru Harabayashi; Ataru Sazawa; Satoru Maruyama; Kanako Kubota; Yoshihiro Matsuno; Takahiro Osawa; Yuichiro Shinno; Akira Kumagai; Masaki Togashi; Hiroyuki Matsuda; Tatsuya Mori; Katsuya Nonomura
Journal:  J Urol       Date:  2010-09       Impact factor: 7.450

2.  High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Jeffrey K Wang; Matthew K Tollefson; Amy E Krambeck; Landon W Trost; R Houston Thompson
Journal:  Urology       Date:  2012-03       Impact factor: 2.649

Review 3.  Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.

Authors:  Michele Marchioni; Giulia Primiceri; Luca Cindolo; Lance J Hampton; Mayer B Grob; Georgi Guruli; Luigi Schips; Shahrokh F Shariat; Riccardo Autorino
Journal:  BJU Int       Date:  2017-07-19       Impact factor: 5.588

Review 4.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

Authors:  Marko Babjuk; Maximilian Burger; Richard Zigeuner; Shahrokh F Shariat; Bas W G van Rhijn; Eva Compérat; Richard J Sylvester; Eero Kaasinen; Andreas Böhle; Joan Palou Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2013-06-12       Impact factor: 20.096

5.  Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management.

Authors:  Armine K Smith; Andrew J Stephenson; Brian R Lane; Benjamin T Larson; Anil A Thomas; Michael C Gong; J Stephen Jones; Steven C Campbell; Donna E Hansel
Journal:  Urology       Date:  2011-05-07       Impact factor: 2.649

6.  Risk of Intravesical Recurrence After Ureteroscopic Biopsy for Upper Tract Urothelial Carcinoma: Does the Location Matter?

Authors:  Sangjun Yoo; Dalsan You; Cheryn Song; Bumsik Hong; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn; In Gab Jeong
Journal:  J Endourol       Date:  2016-11-29       Impact factor: 2.942

7.  The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.

Authors:  Laurent Nison; Morgan Rouprêt; Grégory Bozzini; Adil Ouzzane; François Audenet; Géraldine Pignot; Alain Ruffion; Jean-Nicolas Cornu; Sophie Hurel; Antoine Valeri; Mathieu Roumiguie; Thomas Polguer; Nicolas Hoarau; Olivier Mérigot de Treigny; Evanguelos Xylinas; Alexandre Matte; Stéphane Droupy; Pierre Olivier Fais; Aurélien Descazeaud; Pierre Colin
Journal:  World J Urol       Date:  2012-10-16       Impact factor: 4.226

8.  Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.

Authors:  Hao Lun Luo; Chih Hsiung Kang; Yen Ta Chen; Yao Chi Chuang; Wei Ching Lee; Yuan Tso Cheng; Po Hui Chiang
Journal:  Ann Surg Oncol       Date:  2013-05-10       Impact factor: 5.344

9.  Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma?

Authors:  D A Kulp; D H Bagley
Journal:  J Endourol       Date:  1994-04       Impact factor: 2.942

10.  Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.

Authors:  Hyun Hwan Sung; Hwang Gyun Jeon; Deok Hyun Han; Byong Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han-Yong Choi; Seong Soo Jeon
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more
  7 in total

1.  Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".

Authors:  Yuxuan Song; Yiqing Du; Caipeng Qin; Tao Xu
Journal:  World J Urol       Date:  2022-02-22       Impact factor: 4.226

2.  Whether diagnostic ureteroscopic biopsy and ureteroscopy without biopsy have different impacts on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy?

Authors:  Yuxuan Song; Jingli Han; Caipeng Qin; Yiqing Du; Tao Xu
Journal:  World J Urol       Date:  2022-05-28       Impact factor: 3.661

Review 3.  Outcomes of endoscopic management of upper tract urothelial carcinoma.

Authors:  John J Knoedler
Journal:  Transl Androl Urol       Date:  2020-08

4.  Predictive Value of Preoperative Positive Urine Cytology for Development of Bladder Cancer After Nephroureterectomy in Patients With Upper Urinary Tract Urothelial Carcinoma: A Prognostic Nomogram Based on a Retrospective Multicenter Cohort Study and Systematic Meta-Analysis.

Authors:  Bo Fan; Yuanbin Huang; Shuang Wen; Qiliang Teng; Xinrui Yang; Man Sun; Tingyu Chen; Yan Huang; Yumei Wang; Zhiyu Liu
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

5.  Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.

Authors:  Younsoo Chung; Dong Hwan Lee; Minseung Lee; Hakju Kim; Sangchul Lee; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee; Jong Jin Oh
Journal:  Investig Clin Urol       Date:  2020-02-04

6.  Editorial Comment: Adjuvant Single-Dose Upper Urinary Tract Instillation of Mitomycin C After Therapeutic Ureteroscopy for Upper Tract Urothelial Carcinoma: A Single-Centre Prospective Non-Randomized Trial.

Authors:  João Paulo Martins de Carvalho
Journal:  Int Braz J Urol       Date:  2021 Jan-Feb       Impact factor: 1.541

7.  Re: How to Manage Patients with Suspected Upper Tract Urothelial Carcinoma in the Pandemic of COVID-19?

Authors:  Petrisor Geavlete; Razvan Multescu; Bogdan Geavlete
Journal:  Eur Urol       Date:  2022-01-19       Impact factor: 24.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.